A71623

Cat. No. M53910

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

A71623, a CCK-4-based peptide, is a potent and highly selective CCK-A full agonist.

Molecular Weight	840.96
Formula	C44H56N8O9
CAS Number	130408-77-4
Form	Solid
Solubility (25°C)	DMSO 30 mg/mL
Storage	-20°C, protect from light, dry, sealed

Related Cholecystokinin Receptor Products
Pentagastrin Pentagastrin (ICI-50123) is a synthetic polypeptide that has effects like gastrin when given parenterally.
Proglumide sodium salt Proglumide sodium salt is a non-selective, orally active cholecystokinin (CCK) antagonist.
Lintitript Lintitript (SR 27897) is a highly potent, selective, orally active, competitive and non-peptide cholecystokinin (CCK1) receptor antagonist with an EC50 of 6 nM and a Ki of 0.2 nM. Lintitript displays > 33-fold selectivity more selective for CCK1 than CCK2 receptors (EC50 value of 200 nM).
Lorglumide sodium salt Lorglumide (CR-1409) sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
Gastrin-I (human) Gastrin-I (human) is the endogenous peptide produced in the stomach, which increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.

Catalog